HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy-Reference-Cited by-同舟云学术

HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy

Published:2019-08-16 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Malagnino Vincenzo,Cerva Carlotta,Maffongelli Gaetano,Teti Elisabetta,Foroghi Biland Luca^ORCID,Cesta Novella,De Masi Margherita,Stingone Christof,Armenia Daniele,Svicher Valentina,Salpini Romina,Andreoni Massimo,Sarmati Loredana^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-46976-1.pdf

Reference29 articles.

1. Pinchoff, J. et al. Impact of hepatitis B on mortality and specific causes of death in adults with and without HIV co-infection in NYC, 2000–2011. Epidemiol Infect, 1–11 (2016)

2. Rajbhandari, R., Jun, T., Khalili, H., Chung, R. T. & Ananthakrishnan, A. N. HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV. J Viral Hepatitis 23, 820–829 (2016).

3. Wandeler, G., Gsponer, T., Bihl, F., Bernasconi, E., Cavassini, M., Kovari, H., Schmid, P., Battegay, M., Calmy, A., Egger, M., Furrer, H., Rauch, A. & Swiss, H. I. V. Cohort Study. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J Infect Dis 208, 1454–8 (2013).

4. Thio, C. L. et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360, 1921–1926 (2002).

5. Clifford, G. M. et al. Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma. AIDS 22, 2135–2141 (2008).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy;HIV Medicine;2024-06-04

2. HBcAb Positivity as a Risk Factor for Missing HIV RNA Undetectability after the 3TC+DTG Switch;Viruses;2024-02-23

3. Correlations of intestinal microorganisms with liver and immune functions of patients with human immunodeficiency virus and hepatitis B virus coinfection;African Health Sciences;2023-10-11

4. Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort;Viruses;2023-01-10

5. Hepatitis B–Related Hepatic Flare During Immune Reconstitution Syndrome After Antiretroviral Treatment Initiation in an HBV Surface Antigen–Positive Patient With HIV: Viroimmunological and Histological Characterization;Open Forum Infectious Diseases;2022-08-29